Oral Nicotine Product Awareness and Use Among People Who Smoke and Vape in the U.S
- PMID: 35667923
- PMCID: PMC9509436
- DOI: 10.1016/j.amepre.2022.04.019
Oral Nicotine Product Awareness and Use Among People Who Smoke and Vape in the U.S
Abstract
Introduction: Tobacco-free oral nicotine products are an emerging class of noncombustible nicotine products. Oral nicotine product sales have increased since 2016, although little research has investigated consumer awareness, use, or correlates of oral nicotine product use. The purpose of this analysis was to assess the prevalence and correlates of oral nicotine product awareness and use.
Methods: This paper is a cross-sectional analysis of 2,507 U.S. participants from Wave 3 (February-June 2020) of the International Tobacco Control Four Country Smoking and Vaping Survey, a population-based survey of current and former cigarette smokers and nicotine vaping product users in the U.S. Oral nicotine product awareness and use prevalence were compared with those of heated tobacco products. Analyses conducted in late 2021 assessed the correlates of oral nicotine product awareness and use such as demographic characteristics, tobacco use (cigarettes, nicotine vaping products, smokeless tobacco), and tobacco quit attempts.
Results: Almost 1 in 5 respondents claimed to have heard of oral nicotine products, 3.0% reported ever use, and 0.9% were current users, all of which were lower than for heated tobacco products. Ever use of oral nicotine products was more common among younger adults (e.g., aged 18-24 years), males, and current users of smokeless tobacco. Oral nicotine product prevalence was higher among those who reported having made attempts to stop smoking or vaping.
Conclusions: Oral nicotine product use was low among current and former smokers and nicotine vaping product users. Oral nicotine product users were demographically similar to use among individuals who smoke/vape and also use smokeless tobacco. Future studies are needed to understand emerging oral nicotine products, particularly whether they are being used as product supplements (dual use), replacements (switching), or cessation aids (quitting).
Copyright © 2022 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.Nicotine Tob Res. 2021 Aug 18;23(9):1611-1616. doi: 10.1093/ntr/ntab040. Nicotine Tob Res. 2021. PMID: 33693833 Free PMC article.
-
Characterizing Heated Tobacco Product Use Among Adult Cigarette Smokers and Nicotine Vaping Product Users in the 2018 ITC Four Country Smoking & Vaping Survey.Nicotine Tob Res. 2022 Mar 1;24(4):493-502. doi: 10.1093/ntr/ntab217. Nicotine Tob Res. 2022. PMID: 34669964 Free PMC article.
-
Disposable E-Cigarette Use Prevalence, Correlates, and Associations With Previous Tobacco Product Use in Young Adults.Nicotine Tob Res. 2022 Feb 14;24(3):372-379. doi: 10.1093/ntr/ntab165. Nicotine Tob Res. 2022. PMID: 34379787 Free PMC article.
-
Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence.Harm Reduct J. 2024 Dec 31;21(1):229. doi: 10.1186/s12954-024-01147-y. Harm Reduct J. 2024. PMID: 39736680 Free PMC article. Review.
-
Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: current and emerging evidence.Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1213-1226. doi: 10.1080/17476348.2023.2167716. Epub 2023 Jan 22. Expert Rev Respir Med. 2022. PMID: 36638185 Review.
Cited by
-
Heated Tobacco Products: Awareness, Beliefs, Use and Susceptibility among US Adult Current Tobacco Users, 2021.Int J Environ Res Public Health. 2023 Jan 21;20(3):2016. doi: 10.3390/ijerph20032016. Int J Environ Res Public Health. 2023. PMID: 36767383 Free PMC article.
-
The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.Nicotine Tob Res. 2025 Mar 24;27(4):598-610. doi: 10.1093/ntr/ntae131. Nicotine Tob Res. 2025. PMID: 38880491 Free PMC article.
-
A comprehensive review on oral nicotine pouches: Available scientific evidence and future research needs.Exp Clin Psychopharmacol. 2025 Apr;33(2):123-132. doi: 10.1037/pha0000755. Epub 2024 Dec 2. Exp Clin Psychopharmacol. 2025. PMID: 39621395 Review.
-
Prevalence, safety, and role of nicotine pouches in smoking cessation among smokers and the public in Saudi Arabia.Sci Rep. 2025 Aug 13;15(1):29758. doi: 10.1038/s41598-025-15070-0. Sci Rep. 2025. PMID: 40804318 Free PMC article.
-
Oral nicotine product marketing expenditures in the USA from 2016 to 2023: trends over time by brand and targeted media outlets.Tob Control. 2025 May 15;34(3):382-385. doi: 10.1136/tc-2023-058537. Tob Control. 2025. PMID: 38485232 Free PMC article.
References
-
- HHS, Food and Drug Administration. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act (2016). 81 FR 28973. https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/fdas.... Published September 1, 2021. Accessed May 3, 2022. - PubMed
-
- U.S. Food and Drug Administration. New law clarifies FDA authority to regulate synthetic nicotine. https://content.govdelivery.com/accounts/USFDA/bulletins/30f82ff. Accessed April 11, 2022.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical